05-Dec-2013 - A lawsuit alleging that the US FDA unlawfully detained a batch of acetaminophen API destined for CMO Gemini Pharmaceuticals could have significant impact on the drug industry's definition of an ‘end user.'
04-Dec-2013 - Ideal Cures has launched a new mobile phone ‘app’ designed to help customers make better use of its range of coating products.
03-Dec-2013 - Ingredient supplier ChemCon GmbH has been cleared to make semi-solid dosage forms by German regulators.
02-Dec-2013 - BASF has raises the price of 1,4 Butanediol (BDO) and its derivatives, citing energy costs as a key factor.
27-Nov-2013 - Actavis says it is restructuring a Californian manufacturing facility at a cost of 56 jobs weeks after the announced closure of a plant in North Carolina.
25-Nov-2013 - A £25m (€40.5m) investment at an API facility in Scotland will allow GSK closer control over its manufacturing network efficiency, the firm says.
19-Nov-2013 - Royal DSM wants to merge its pharmaceutical products business with Patheon and has signed a deal with the latter's owner, investment group JLL Partners.
18-Nov-2013 - GSK has announced plans for a new manufacturing plant to "bring more medicines to the people of India" weeks after revealing that some drug wholesalers in the country have stopped buying its products.
12-Nov-2013 - Concerns recently introduced import laws would cause EU-wide API shortages now appear unfounded, but European industry groups say the buffering effects of stockpiling mean it is still too early to be sure supplies will not be affected.
11-Nov-2013 - Evonik has upped its capabilities in highly potent active pharmaceutical ingredients (HPAPI) citing the increased market growth of oncology drugs.
07-Nov-2013 - Evonik Industries has announced plans to increase what it charges for excipients used in modified release formulations next year, citing rising costs.
06-Nov-2013 - A third Amarin supplier has confirmed it will continue to supply the firm with pharma-grade omega-3 despite a US FDA panel recommending against a label extension for the heart pill Vascepa.
05-Nov-2013 - DSM says it has not found the right partner for its pharmaceutical products business and is continuing to look for a collaborator with which it can grow in Asia.
05-Nov-2013 - A new tableting excipient eliminates the need for wet granulation and saves up to 60% on overall manufacturing costs according to developer Dow.
05-Nov-2013 - An IPEC-affiliated coalition is calling on USP (US Pharmacopoeia) to allow for the determination of physiologically relevant bioaccessible elemental impurity content for pharmaceutical products and components.
04-Nov-2013 - Granules India has outlined plans to buy drug intermediate and API maker Auctus Pharma, set up an actives R&D site and announced its intention to wind up its ‘shell’ operation in Singapore.
31-Oct-2013 - Lonza says its pharmaceutical business ‘performed as expected’ in the third quarter and that its restructuring efforts – which have seen it cut nearly 800 jobs– are on track to deliver productivity gains.
30-Oct-2013 - Novasep has confirmed it will keep supplying Amarin with omega-3 API as the US FDA withdraws special status afforded to Vascepa trial.
30-Oct-2013 - API, drug intermediates and formulations firm Granules India ended the second quarter of fiscal 2013 with higher revenue and profit thanks to gains made by all three of its units.
30-Oct-2013 - Teva CEO Jeremy Levin has resigned just days after he denied rumours he would leave and called the speculation "an invention."
29-Oct-2013 - French CMO Novasep has received the thumbs up from US regulators at two of its European API manufacturing facilities.
28-Oct-2013 - Regulatory pressure for risk-based supply chain management is increasing excipient suppliers’ audit burden according to the team preparing to launch the 'excipact' certification scheme as an independent association.
23-Oct-2013 - Omega-3 supplier BASF will continue to produce the API for Amarin, as well as its competitor GlaxoSmithKline, despite an FDA panel saying that Amarin’s drug should not be approved for a broader population.
22-Oct-2013 - Azelis says its partnership with JH Nanhang (JHNH) will feed a large demand for polyvinylpyrolidones (PVP) excipients and bring the China-made ingredients to new markets.
21-Oct-2013 - Drugmakers, fine chemicals firms, delivery technology manufacturers and processing system developers from around the world meet in Frankfurt, Germany.
Dispatches from AAPS
The US FDA is working with GEA to validate continuous manufacturing as the pharma industry enters “the start...
The US FDA and European Medicines Agency (EMA) is now offering additional joint guidance on the concept...
Novartis has confirmed it is closing a UK facility as part of a global R&D review but...
In one of the largest healthcare fraud settlements in US history, Johnson & Johnson has pleaded guilty to...
The acquisition of Bend Research by Capsugel may be “a marriage made in heaven” for customers, the...